Akita Biosciences cover photo
Akita Biosciences

Akita Biosciences

生物技术研究

Columbus,Ohio 725 位关注者

Innovating for a Healthier Tomorrow

关于我们

Akita Biosciences is a biotech organization pioneering novel intranasal therapies that help people live healthy and vibrant lives. Akita’s lead product is a once-daily nasal spray that is taken proactively to help reduce the risk of common respiratory infections such as Influenza A, Influenza B, SARS-CoV-2, RSV, Adenovirus, E. coli, and K. Pneumonia. Our proprietary drug delivery platform creates a barrier that controls mucosal absorption and optimizes the residence time across a wide range of molecules and biologics.

网站
https://www.akitabiosciences.com
所属行业
生物技术研究
规模
2-10 人
总部
Columbus,Ohio
类型
私人持股
创立
2022

地点

Akita Biosciences员工

动态

  • ?? Hot off the press ?? — Akita Biosciences is excited to announce the publication of our “PCANS” nasal spray technology in the prestigious scientific journal Advanced Materials. Our vision is to spread health and wellness through innovative nasal therapies that empower the body's natural defenses. The peer-reviewed study, 'Toward a Radically Simple Multi-Modal Nasal Spray for Preventing Respiratory Infections,' marks an important step forward in that effort. Currently, Akita Biosciences markets Profi Nasal Spray as a cosmetic product for nasal hygiene, with this study highlighting its potential applications as a medical device or drug. The technology could help protect high-risk groups such as children, the immunocompromised, and the elderly, as well as anyone looking to reduce the risk of respiratory infections. ? The spray is designed to form a protective gel-like barrier in the nose that lasts up to 8 hours, capturing pathogen-laden droplets, physically blocking them their entry, and rapidly neutralizing them. It’s formulated with well-established ingredients used in previously approved nasal sprays, which helps streamline its path to broader applications and supports ease of translation. In pre-clinical studies, PCANS demonstrated strong activity against a wide range of respiratory pathogens, for example the ones causing influenza, COVID-19, and RSV, and also a pneumonia-causing bacteria. ? This research was performed at Brigham and Women's Hospital and was made possible through the The Gillian Reny Stepping Strong Center for Trauma Innovation. ? Congratulations to the incredible researchers behind this breakthrough, including John Joseph, Helna Mary Baby, Joselyn Rojas Quintero, Dongtak Lee, Yohannes Tesfaigzi, Jeff Karp, Nitin Joshi, and more. Read the study here: https://lnkd.in/e-GJa2kp

    Toward a Radically Simple Multi‐Modal Nasal Spray for Preventing Respiratory Infections

    Toward a Radically Simple Multi‐Modal Nasal Spray for Preventing Respiratory Infections

    onlinelibrary.wiley.com

  • ?? We are thrilled to announce that Robert Hanson, former President of Constellation Brands and CEO of American Eagle, has joined Akita Biosciences' Advisory Board! ?? Robert brings unparalleled expertise in brand growth, strategic direction, and market expansion from his leadership roles at Constellation Brands, John Hardy Global, American Eagle Outfitters, and Levi Strauss & Co. His insights will be instrumental in establishing our Profi? Nasal Spray as a national brand and driving our retail strategy forward. With colds, flu, and COVID continuing to pose challenges to our health, traditional supplements fall short of providing targeted protection. Our approach focuses on the nasal passages—where airborne germs, allergens, and irritants first enter the body. With Robert’s guidance, we’re setting a new standard for health and wellness in an increasingly airborne world. ?? Learn more at www.profispray.com and www.akitabiosciences.com. #HealthAndWellness #NasalCare #ProfiNasalSpray #ActiveDefense #AkitaBiosciences #Innovation

  • Akita Biosciences转发了

    We’re thrilled to share some exciting news with you! Akita Biosciences co-founder and scientific advisory board member,?Dr. Jeff Karp, was recently featured on the esteemed Moonshots podcast hosted by Peter H. Diamandis. This year’s notable guests include visionaries like Elon Musk, Dean Kamen, Eric Schmidt, and Catherine Wood. In this engaging episode, Dr. Karp shares his remarkable journey of overcoming early challenges with ADHD, his philosophy of radical simplicity, and his unique problem-solving process. He also provides insights into the cutting-edge science happening in his labs, including a deep dive into Profi Nasal Spray (45 min. mark), the development of innovative masks (52:30 min. mark), and his recent book,?Lit. This episode is a testament to the critical importance of raising awareness about airborne germs and effective mitigation strategies. Don't miss out on this fascinating conversation. https://lnkd.in/eprn5Hpm

  • We’re thrilled to share some exciting news with you! Akita Biosciences co-founder and scientific advisory board member,?Dr. Jeff Karp, was recently featured on the esteemed Moonshots podcast hosted by Peter H. Diamandis. This year’s notable guests include visionaries like Elon Musk, Dean Kamen, Eric Schmidt, and Catherine Wood. In this engaging episode, Dr. Karp shares his remarkable journey of overcoming early challenges with ADHD, his philosophy of radical simplicity, and his unique problem-solving process. He also provides insights into the cutting-edge science happening in his labs, including a deep dive into Profi Nasal Spray (45 min. mark), the development of innovative masks (52:30 min. mark), and his recent book,?Lit. This episode is a testament to the critical importance of raising awareness about airborne germs and effective mitigation strategies. Don't miss out on this fascinating conversation. https://lnkd.in/eprn5Hpm

相似主页

查看职位